Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIMI NASDAQ:JXG NASDAQ:JXJT NASDAQ:MEDS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIMIBIMI$0.01+4,900.0%$0.00$0.00▼$1.49$116K-0.742,798 shs5,200 shsJXGAquaron Acquisition$1.05+1.0%$2.07$0.55▼$8.40$2.34M0.9395,806 shs39,630 shsJXJTJX Luxventure$1.04-2.8%$2.13$0.78▼$2.10$630K0.91109,388 shs252,675 shsMEDSTRxADE HEALTH$2.12+1.7%$1.13$3.69▼$44.56$2.97M2.32207,831 shs357,882 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIMIBIMI+4,900.00%+9,900.00%+9,900.00%+4,900.00%-99.26%JXGAquaron Acquisition+0.96%+9.38%-56.61%-54.35%+104,999,900.00%JXJTJX Luxventure0.00%+1.97%-57.02%-54.78%-22.10%MEDSTRxADE HEALTH0.00%+33.02%+132.09%+152.09%-85.65%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBIMIBIMIN/AN/AN/AN/AN/AN/AN/AN/AJXGAquaron AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AJXJTJX LuxventureN/AN/AN/AN/AN/AN/AN/AN/AMEDSTRxADE HEALTHN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIMIBIMI 0.00N/AN/AN/AJXGAquaron Acquisition 0.00N/AN/AN/AJXJTJX Luxventure 0.00N/AN/AN/AMEDSTRxADE HEALTH 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIMIBIMI$12.63M0.01N/AN/AN/A∞JXGAquaron Acquisition$49.84M0.05$2.76 per share0.38$5.74 per share0.18JXJTJX Luxventure$38.49M0.02$5.78 per share0.18$15.33 per share0.07MEDSTRxADE HEALTH$7.45M0.40N/AN/A$0.45 per share4.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIMIBIMI-$22.39MN/A0.00∞N/AN/AN/AN/AN/AJXGAquaron Acquisition$3.07MN/A0.00∞N/AN/AN/AN/AN/AJXJTJX Luxventure$3.04MN/A0.00∞N/AN/AN/AN/AN/AMEDSTRxADE HEALTH-$17.84MN/A0.00∞N/A-149.81%-196.79%-112.21%8/7/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBIMIBIMIN/AN/AN/AN/AN/AJXGAquaron AcquisitionN/AN/AN/AN/AN/AJXJTJX LuxventureN/AN/AN/AN/AN/AMEDSTRxADE HEALTHN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBIMIBIMIN/AN/AN/AJXGAquaron AcquisitionN/A1.321.32JXJTJX LuxventureN/AN/AN/AMEDSTRxADE HEALTHN/A4.184.18Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIMIBIMI0.11%JXGAquaron Acquisition5.32%JXJTJX Luxventure5.32%MEDSTRxADE HEALTH5.68%Insider OwnershipCompanyInsider OwnershipBIMIBIMI69.02%JXGAquaron AcquisitionN/AJXJTJX LuxventureN/AMEDSTRxADE HEALTH48.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIMIBIMI52011.59 million3.59 millionNot OptionableJXGAquaron Acquisition572.25 millionN/AN/AJXJTJX Luxventure57606,000N/ANot OptionableMEDSTRxADE HEALTH501.41 million725,000Not OptionableJXJT, MEDS, JXG, and BIMI HeadlinesRecent News About These CompaniesWellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder ValueMay 28, 2025 | accessnewswire.comAOragenics gears up for Phase II trials, appoints new CEOJanuary 21, 2025 | msn.comTRxADE Health (NASDAQ: MEDS)November 23, 2024 | fool.comScienture Holdings, Inc. (SCNX)November 15, 2024 | finance.yahoo.comTravis County extends opioid public health crisis declarationNovember 13, 2024 | msn.comMedicaid covers GLP-1 meds for obesity in just 13 states, analysis findsNovember 5, 2024 | medicalxpress.comMYou Can Now Get Prescription Weight Loss Drugs Like Ozempic From An Online Telehealth Visit. But Is It Safe?November 5, 2024 | msn.comADHD drugs' impact on brain health, quality of life: What we knowOctober 31, 2024 | medicalnewstoday.comMUS releases preliminary list of $2 generic drugs for Medicare recipientsOctober 11, 2024 | reuters.comMedications increase risk for heat-related illnesses during extended heat waveOctober 11, 2024 | msn.comHarvard Health Ad Watch: Got side effects? There's a medicine for thatOctober 11, 2024 | msn.comCMS releases RFI, sample list of prescription drugs that may be included under proposed Medicare $2 Drug List ModelOctober 11, 2024 | aha.orgAThe end of a shortage of popular weight-loss drugs may mean many people lose access to themOctober 11, 2024 | msn.comWeight-loss drugs are life-changing — and expensive. Here's one woman's solution.September 27, 2024 | aol.comAOlder migraine drugs more effective than some newer options, study findsSeptember 25, 2024 | medicalnewstoday.comMGoogle trends reveals surge in ADHD medication searches during COVID-19 pandemicSeptember 24, 2024 | medicalxpress.comMTRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”September 24, 2024 | markets.businessinsider.comScienture Holdings Inc (SCNX)September 24, 2024 | sg.finance.yahoo.comTriptans better at relieving migraine pain than recently marketed and more expensive drugsSeptember 23, 2024 | news-medical.netNTypes of Medications for Heart Attack Prevention and TreatmentSeptember 21, 2024 | verywellhealth.comVMedia Sentiment Over TimeJXJT, MEDS, JXG, and BIMI Company DescriptionsBIMI NASDAQ:BIMI$0.01 +0.01 (+4,900.00%) As of 07/21/2025 02:02 PM EasternBIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services; and operates two private hospitals in China. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. BIMI Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.Aquaron Acquisition NASDAQ:JXG$1.05 +0.01 (+0.96%) As of 07/21/2025 03:59 PM EasternJX Luxventure Group, Inc. engages in the design, manufacture, distribution, and sale of casual menswear. It operates through the following segments: Tourism Products, Technology, and Cross-Board Merchandise. The The company was founded by Anna Polemis on January 26, 2012, and is headquartered in Haikou, China.JX Luxventure NASDAQ:JXJT$1.04 -0.03 (-2.80%) As of 07/18/2025JX Luxventure Limited provides tourism services and supplying related products in the People's Republic of China. The company operates in Technology, Tourism Service, and Cross-Border E-Commerce segments. It engages in the sale of packaged group tour services; and provides health care, personal care, cosmetics, maternal and child, pet-related, universal cuisine and household products, and pre-owned electric cars through online and offline platforms. The company also offers real-time inventory management software solutions, which allows merchants to track product inventory levels in real-time, enabling them to make informed decisions regarding procurement and distribution, ultimately minimizing stockouts, and excess inventory; order processing and fulfillment software solutions that facilitates seamless order processing and fulfillment, ensuring timely delivery of products to customers and enhancing customer satisfaction; compliance and regulatory support software solutions, which equipped with tools to help businesses navigate complex cross-border regulatory requirements, ensuring compliance with various international trade laws and regulations; data analytics and reporting software solutions provides advanced data analytics and reporting capabilities, empowering merchants with valuable insights into their cross-border operations; and scalability and flexibility software solutions. In addition, it offers airline ticket and sales agent, tourism, and selling carrier services. The company was formerly known as KBS Fashion Group Limited and changed its name to JX Luxventure Limited in October 2021. JX Luxventure Limited is headquartered in Haikou, the People's Republic of China.TRxADE HEALTH NASDAQ:MEDS$2.12 +0.04 (+1.68%) As of 07/18/2025TRxADE HEALTH, Inc. operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Domino’s Delivers Another Discounted Entry for Income Investors TSLA Earnings Week: Can Tesla Break Through $350? Analysts See Upside in These 5 Stocks That Just Raised Dividends MarketBeat Week in Review – 07/14 - 07/18 Q2 Could Be the Catalyst PayPal Investors Have Been Waiting For Kinder Morgan: At the Hotspot of the Natural Gas Revolution Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
